Latest Articles
-
Will The Rally In Pfizer Stock Continue After A Large 21% Rise In A Month?
[Updated: Nov 18, 2021] Pfizer Stock Update The stock price of Pfizer (NYSE: PFE) has seen a rise of 21% in a month following multiple positive developments, including positive data for its oral Covid-19 treatment pill, upbeat Q3 results, and mo...
-
Will Pfizer Stock Continue To Rise?
[Updated: Nov 8, 2021] PFE Stock Rise The stock price of Pfizer (NYSE: PFE) surged 11% in a single day on Friday Nov 5, 2021. The rise can be attributed to the company announcing positive data for its oral pill for the treatment of Covid-19. Pfi...
-
Company Of The Day: Pfizer
What? The U.S. Centers for Disease Control and Prevention has formally authorized the Pfizer (NYSE:PFE) – BioNTech Covid-19 vaccine for children between the ages of 5 and 11 years old. So What? Pfizer stock remains up by about 24% year-t...
-
Is Pfizer Stock Set To See Higher Levels Post Q3 Results?
Pfizer (NYSE: PFE) is scheduled to report its Q3 2021 results on Tuesday, November 2. We expect the company to likely post revenue and earnings well above the consensus estimates, primarily led by its Covid-19 vaccine. Pfizer should see an overal...
-
A Year Since Pfizer’s Big Breakthrough, Are Vaccine Stocks Still Worth Investing In?
It’s been almost a year since Pfizer (NYSE:PFE) published incredibly strong efficacy data from its phase 3 Covid-19 vaccine trials, setting the stage for one of the largest inoculation drives in history. Our theme of Covid-19 Vaccine Stoc...
-
Here’s Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month
[Updated: 9/16/2021] Pfizer Stock Decline A few weeks back, we discussed that Pfizer’s (NYSE: PFE) stock price could rebound over a one-month period after falling 4% in a week, based on its historical performance. However, PFE stock has se...
-
Company Of The Day: Pfizer
What? Pfizer’s (NYSE:PFE) Covid-19 vaccine could be available to children from ages five to eleven as soon as the end of October, per a report from Reuters. Why? Pfizer and its partner BioNTech could have sufficient data from clinical t...
-
After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?
[Updated: 8/25/2021] PFE Stock Decline The stock price of Pfizer (NYSE: PFE) reached an all-time high of $52 last week before a recent sell-off in Covid-19 vaccine stocks drove PFE down to its current level of around $48. PFE stock has fallen 4%...
-
What Are The New Developments For Pfizer’s Covid-19 Vaccine?
Covid-19 vaccine stocks are back in focus, as cases in the U.S. surge with the spread of the highly infectious Delta variant of the virus. The seven-day average for Covid-19 cases stood at around 150,000 as of August 21, up by about 3x over the l...
-
Pfizer Stock Has Risen 11% In A Month But Will The Gains Continue?
[Updated: 8/3/2021] PFE Stock Update The stock price of Pfizer (NYSE: PFE) has seen an 11% rise over the last twenty-one trading days, and most of the gains have come over the last ten trading days, after the company reported strong Q2 results, ...
-
Pfizer’s Q2 Earnings Snapshot
[Updated: 7/28/2021] Pfizer Earnings Update Pfizer (NYSE: PFE) today reported its Q2 results, which were below our expectations but beat the consensus estimates. The company reported revenues of $19.0 billion, lower than our forecast of $21.7 b...
-
Is Pfizer Stock Set To See Higher Levels Post Q2 Results?
Pfizer (NYSE: PFE) is scheduled to report its Q2 2021 results on Wednesday, July 28. We expect the company to likely post revenue and earnings well above the consensus estimates, primarily led by its Covid-19 vaccine. Pfizer should see an overall...
-
What’s New With Pfizer’s Covid-19 Vaccine?
Pfizer (NYSE: PFE) has indicated that a third dose of its vaccine may be needed within six to 12 months after full vaccination, as initial immunity wanes and as new and more aggressive variants of the Coronavirus continue to spread. The company...
-
Company Of The Day: Pfizer
What? Pfizer (NYSE:PFE) and its German partner BioNTech intend to begin clinical trials for an updated version of their Covid-19 vaccine that targets the Delta variant of the Coronavirus. Why? The Delta variant apparently more transmissible ...
-
Is Pfizer Stock A Better Bet Compared To Eli Lilly?
We think that Pfizer (NYSE:PFE) currently is a better pick compared to Eli Lilly & Company (NYSE:LLY) . PFE stock trades at about 5x trailing revenues, compared to around 8x for LLY. Does this gap in Pfizer’s valuation make sense? We...
